Endure Biotherapeutics

Endure Biotherapeutics

Pre-clinical
Cambridge, United StatesFounded 2020endurebio.com

Engineered Native Bacteria A novel platform for engineering therapeutic strains that persist in the body. Engraftable Live Biotherapeutics Endure Biotherapeutics® is leading the discovery, development, and commercialization of engineered, engraftable live biotherapeutics for the treatment of genetic and chronic diseases. Resident Strains, Long-term Benefits Unlike other gut-focused microbiome companies, our powerful therapeutic platform engineers bacterial

Founded
2020
Focus
Microbiome

About

Engineered Native Bacteria A novel platform for engineering therapeutic strains that persist in the body. Engraftable Live Biotherapeutics Endure Biotherapeutics® is leading the discovery, development, and commercialization of engineered, engraftable live biotherapeutics for the treatment of genetic and chronic diseases. Resident Strains, Long-term Benefits Unlike other gut-focused microbiome companies, our powerful therapeutic platform engineers bacterial

Funding History

2

Total raised: $20M

Series A$15MUndisclosedJun 15, 2022
Seed$5MUndisclosedJun 15, 2020

Company Info

TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile